论文部分内容阅读
为了总结国产治疗高血压药物萝芙木制剂的试验研究和生产等有关问题,卫生部在9月7日至10日在北京召开了国产萝芙木制剂座谈会,出席会议的有化工部、商业部和云南、广西、广东省、北京(等有关省、市和自治区的卫生厅、局)、昆明化工局、广州化工研究所、中国医学科学院、卫生部药品检验所和北京有关临床医院计25个单位,包括专家、临床医师、检验、研究、利学技术人员和药政及生产管理人员共四十余人。
In order to summarize the experimental research and production and other related issues of domestically produced high blood pressure drug Rauwolfi preparations, the Ministry of Health held a domestic Rauwolfian pharmaceutical product symposium in Beijing from September 7 to September 10, attended by representatives from Ministry of Chemical Industry, Commercial Ministry of Science and Technology and the relevant clinical hospitals in Yunnan, Guangxi, Guangdong and Beijing (and other related provinces, municipalities and autonomous regions), Kunming Bureau of Chemical Industry, Guangzhou Institute of Chemical Industry, Chinese Academy of Medical Sciences, Ministry of Health and relevant clinical hospitals in Beijing. A total of more than 40 people, including experts, clinicians, inspectors, researchers, technologists, pharmacists and production managers, were set up.